Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1229593

registered interest
date	28/08/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish a national cancer recovery plan to tackle the backlog of cancer care resulting from the covid-19 outbreak.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	81799
answer	answer is ministerial correction date of answer 21/09/2020 answer text <p>As set out in the Terms of Reference of a letter sent to NHS Providers on 31 July 2020, a National Cancer Taskforce will be established, and publish a national cancer recovery plan in the near future. The Terms of Reference are available at the following link:</p><p><a href="https://www.england.nhs.uk/publication/cancer-forums-and-groups-terms-of-reference/" target="_blank">https://www.england.nhs.uk/publication/cancer-forums-and-groups-terms-of-reference/</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 21/09/2020 17:09:17 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1219228

registered interest
date	29/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Protective Clothing: Manufacturing Industries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he is taking steps with UK manufacturers to ensure that the country is self-sufficient in PPE production and supporting British enterprises; and if he will make a statement.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	66848
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>Lord Deighton is leading the Government effort to unleash the potential of British industry to manufacture personal protective equipment (PPE) for the health and social care sectors to create self-sufficient production of PPE for the United Kingdom. We are building up UK manufacturing with signed contracts to manufacture over 2 billion items of PPE through UK-based manufacturers, including facemasks, visors, gowns and aprons.</p><p>This includes Survitec, a survival technology company, who began producing gowns at the beginning of June; Bolle, who manufacture protective eyewear, will make 6.5 million visors over the course of the pandemic; Jaguar Land Rover are now manufacturing 14,000 visors/week for healthcare staff; Don &amp; Low will be manufacturing 12 million metres squared of fabric for gowns over the next six months, with the first delivery expected later this month; Burberry is manufacturing non-surgical gowns at its factory in Castleford and sourcing masks through its supply chain. To date, the company has donated over 100,000 pieces of PPE to the National Health Service and healthcare charities.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/07/2020 11:25:01 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1199796

registered interest
date	02/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people with blood cancer have been removed from the shielding list by (a) clinicians and (b) GPs in England.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	53399
answer	answer is ministerial correction date of answer 12/06/2020 answer text <p>The shielded patient list is dynamic – general practitioners and specialists continue to make clinical judgements based the shielding criteria, that may result in those who had initially been advised to shield from COVID-19 no longer being advised to do so. Doctors have also been provided with guidance to support these decisions, which should be made following discussion with the patient and taking into account their individual clinical circumstances.</p><p>Information on the number of patients removed from the shielded patient list is not held centrally.</p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 53400 question first answered 12/06/2020 12:24:33 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1199797

registered interest
date	02/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what evidence his Department based it's decision on for the removal of blood cancer patients from the covid-19 shielding list.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	53400
answer	answer is ministerial correction date of answer 12/06/2020 answer text <p>The shielded patient list is dynamic – general practitioners and specialists continue to make clinical judgements based the shielding criteria, that may result in those who had initially been advised to shield from COVID-19 no longer being advised to do so. Doctors have also been provided with guidance to support these decisions, which should be made following discussion with the patient and taking into account their individual clinical circumstances.</p><p>Information on the number of patients removed from the shielded patient list is not held centrally.</p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 53399 question first answered 12/06/2020 12:24:33 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1199798

registered interest
date	02/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to ensure that clinical criteria will be in place before further changes are made to the covid-19 shielding list.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	53401
answer	answer is ministerial correction date of answer 12/06/2020 answer text <p>The Chief Medical Officer (CMO) for England, working with the CMOs of the devolved administrations and other senior clinicians, commissioned NHS Digital to produce a list of vulnerable people at “high risk” of complications from COVID-19, who should be shielded for at least 12 weeks.</p><p>The next review point for the social distancing measures will take place the week commencing 15 June. As part of this, we will consider the next steps for shielding beyond 30 June. We will also review the risks for the clinically extremely vulnerable and assess whether the shielding period needs to be extended or whether it is possible for the shielding guidance to be eased further. We will base our assessment on clinical advice from our medical experts, and the best data available about the prevalence of COVID-19 in the community.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 12/06/2020 12:27:13 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1194293

registered interest
date	11/05/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 May 2020 to Question 40579, on Blood Cancer: Medical Treatments, how many people with blood cancer have had a stem cell transplant in each of the last six months for which data is available.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	45135
answer	answer is ministerial correction date of answer 19/05/2020 answer text <p>NHS England and NHS Improvement do not collect data for the number of haematopoietic stem cell transplants (HSCT) by condition.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 19/05/2020 12:29:05 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1193066

registered interest
date	05/05/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which covid-free hospitals are specifically dedicated to the treatment of people with cancer; and on what date each such hospital started in that capacity.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	43620
answer	answer is ministerial correction date of answer 29/05/2020 answer text <p>Details of all the facilities currently being used for cancer treatment are not collected centrally. This will be a mix of National Health Service and independent sector facilities.</p><p>NHS England and NHS Improvement have published guidance and supported the development of ‘hubs’ for cancer surgery. Hubs are being developed in all 21 Alliance areas across England and are already fully or partially operational in at least 18 areas. NHS England and NHS Improvement are working now with all Cancer Alliances on plans for the next phases of service delivery.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 29/05/2020 15:18:26 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1193067

registered interest
date	05/05/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many of the people who have been advised by the Government to shield at home for 12 weeks in response to the covid-19 outbreak (a) are undergoing active chemotherapy (b) have lung cancer who are undergoing radical radiotherapy; (c) have a cancer of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment (d) are having immunotherapy or other continuing antibody treatments for cancer; (e) are having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors; (f) have had bone marrow or stem cell transplants in the last six months, or who are still taking immunosuppression drugs; (g) have severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary; (h) have severe combined immunodeficiency and homozygous sickle cell or other rare diseases and inborn errors of metabolism that significantly increase the risk of infections; (i) are on immunosuppression therapies sufficient to significantly increase risk of infection and (j) are pregnant with significant heart disease, congenital or acquired.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	43621
answer	answer is ministerial correction date of answer 29/05/2020 answer text <p>This data is currently unavailable.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 29/05/2020 15:30:36 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1193068

registered interest
date	05/05/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chemotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people received chemotherapy treatment in (a) April 2019 and (b) April 2020 for the treatment of (i) breast cancer, (ii) bowel cancer, (iii) lung cancer, (iv) blood cancer and (v) prostate cancer.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	43622
answer	answer is ministerial correction date of answer 29/05/2020 answer text <p>The data in the following table shows first or subsequent treatment of all anti-cancer drug regimens (including ‘cytotoxic chemotherapy’, ‘hormone therapy’, ‘immunotherapy’ and ‘other’) for April 2019:</p><table><tbody><tr><td><p>Breast</p></td><td><p>Lower Gastrointestinal</p></td><td><p>Lung</p></td><td><p>Haematological</p></td><td><p>Urological</p></td></tr><tr><td><p>3,458</p></td><td><p>1,060</p></td><td><p>1,247</p></td><td><p>1,950</p></td><td><p>3,354</p></td></tr></tbody></table><p>The data for April 2020 is due to be published in June 2020.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 29/05/2020 15:13:14 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1193069

registered interest
date	05/05/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many two week urgent cancer referrals there were in (a) April 2019 (b) April 2020 for suspected (i) breast cancer, (ii) bowel cancer, (iii) lung cancer, (iv) blood cancer and (v) prostate cancer.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	43623
answer	answer is ministerial correction date of answer 13/05/2020 answer text <p>The data on how many two week urgent cancer referrals there were in April 2019 and April 2020 for suspected breast cancer, bowel cancer, lung cancer, blood cancer and prostate cancer is not available in the format requested.</p><p>Data on urgent two week wait cancer referrals by suspected tumour group is collected and published by NHS England and available at the following link: <a href="https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/</a></p><p>Data for April 2020 will be published on 11 June 2020.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 13/05/2020 11:12:35 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith